Symptoms and Disease Course of STAT3-GOF
At a Glance
STAT3-GOF usually begins in early childhood and can cause swollen lymph nodes or spleen, autoimmune blood-cell problems, infections, poor growth, digestive symptoms, and lung disease. Symptoms vary widely, so caregivers need an individualized fever and emergency plan.
STAT3 Gain-of-Function (STAT3-GOF) syndrome is a multisystem condition, meaning it can affect many different parts of the body at once. Because the STAT3 protein is active in nearly every tissue, the “stuck thermostat” in the immune system doesn’t just affect one organ; it can impact the blood, gut, lungs, and growth [1][2].
Symptoms typically begin early, often around the age of two or three [1][3]. However, no two children will have the exact same journey. This is due to variable expressivity, which means that even people with the same genetic variant can have very different symptoms and severity [4].
Recognizing Symptoms & The Individualized Fever Plan
Managing STAT3-GOF requires knowing which symptoms are part of your baseline and which require urgent action. Because children with immune dysregulation or those on immunosuppressive medication can have unusual responses to illness, standard childhood triage advice does not apply. Fever can be absent or blunted in an immunosuppressed child, particularly those on biologics or JAK inhibitors.
Work with your treating team to create a written, individualized fever and emergency action plan that includes the exact temperature threshold for your child, after-hours contact numbers, and clear instructions for emergency departments.
Seek same-day contact or urgent assessment according to your treating team for:
- Fever that meets your team’s specific temperature threshold.
- Unwell appearance (extreme lethargy, confusion, or sepsis-like symptoms, even without a fever).
- Dehydration or inability to keep fluids down.
- Respiratory Distress: Any difficulty breathing, blue tint to the lips, or very fast breathing [5].
- Severe Bleeding: Nosebleeds that won’t stop, blood in the stool, vomiting blood, or numerous small purple spots (petechiae) [6].
- Neurological Changes: Sudden confusion, extreme lethargy, or weakness on one side of the body [6].
- Rapidly enlarging lymph nodes that change significantly from baseline.
Common Early Symptoms
In a large international cohort of 191 patients, the first signs of STAT3-GOF often involved the immune system attacking the body’s own cells or building up in certain tissues:
- Lymphoproliferation (73% of cases): This is the most common feature. It involves the accumulation of immune cells, leading to persistently swollen lymph nodes (lymphadenopathy) or an enlarged spleen (splenomegaly) [1][7].
- Autoimmune Cytopenias (67% of cases): This occurs when the immune system attacks and destroys blood cells. The most frequent types are Immune Thrombocytopenia (ITP), which affects platelets and can cause easy bruising or bleeding, and Autoimmune Hemolytic Anemia (AIHA), which destroys red blood cells and can cause severe fatigue or paleness [1][7].
- Infections (72% of cases): While the immune system is overactive in attacking the body, it is often less effective at fighting external germs due to specific immune abnormalities, leading to frequent respiratory or skin infections [1].
Impact on Growth and Development
One of the most distinct features of STAT3-GOF compared to other immune disorders is its effect on a child’s growth. In a systematic review with growth data on 21 patients, 15 experienced postnatal growth failure, which means they fall behind on the growth charts after birth [3].
This growth delay isn’t just about nutrition; it is often linked to the way the body processes growth hormones. Some children have partial growth hormone insensitivity, where the body makes enough hormone but the cells cannot use it effectively [8]. Additionally, the condition can cause endocrinopathies (hormone system disorders), such as thyroiditis (inflammation of the thyroid) or early-onset diabetes [3][9]. Doctors also recommend monitoring for delayed puberty as part of long-term care [10].
Organ-Specific Symptoms
As the disease progresses, it may affect other major organs:
- The Gut (Enteropathy): About 57% of patients in one review developed digestive issues that can mimic celiac disease or inflammatory bowel disease (IBD). This can cause chronic diarrhea, weight loss, and “silent” inflammation in the intestines that persists even when a child feels okay [3][11].
- The Lungs: Lung involvement can range from mild scarring to more serious interstitial lung disease (ILD), which affects the ability of the lungs to move oxygen into the blood and requires specialist care [12][13].
Common questions in this guide
What are the earliest signs of STAT3-GOF in a child?
How can STAT3-GOF affect a child's growth and hormones?
What digestive symptoms can STAT3-GOF cause?
Can STAT3-GOF affect a child's lungs?
When should I seek urgent help for a child with STAT3-GOF?
Will every child with STAT3-GOF have the same symptoms?
Get notified when new evidence is published on STAT3-related early-onset multisystem autoimmune disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.
Leiding JW, Vogel TP, Santarlas VGJ, et al.
The Journal of allergy and clinical immunology 2023; (151(4)):1081-1095 doi:10.1016/j.jaci.2022.09.002.
PMID: 36228738 - 2
STAT3 gain-of-function syndrome.
Vogel TP, Leiding JW, Cooper MA, Forbes Satter LR
Frontiers in pediatrics 2022; (10()):770077 doi:10.3389/fped.2022.770077.
PMID: 36843887 - 3
Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.
Fabre A, Marchal S, Barlogis V, et al.
The journal of allergy and clinical immunology. In practice 2019; (7(6)):1958-1969.e9 doi:10.1016/j.jaip.2019.02.018.
PMID: 30825606 - 4
Clinical and Immunological Heterogeneity in Japanese Patients with Gain-of-Function Variants in STAT3.
Tanita K, Sakura F, Nambu R, et al.
Journal of clinical immunology 2021; (41(4)):780-790 doi:10.1007/s10875-021-00975-y.
PMID: 33501615 - 5
A Novel STAT3 Gain-of-Function Mutation in Fatal Infancy-Onset Interstitial Lung Disease.
Deng M, Li Y, Li Y, et al.
Frontiers in immunology 2022; (13()):866638 doi:10.3389/fimmu.2022.866638.
PMID: 35677041 - 6
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.
Ciullini Mannurita S, Goda R, Schiavo E, et al.
Frontiers in immunology 2020; (11()):620046 doi:10.3389/fimmu.2020.620046.
PMID: 33519826 - 7
ALPS-like Disorder Linked with STAT3 Mutation: De novo Variant with Bicytopenia and Literature Review.
Mohammadi A, Esfahani ZH, Abolhassani H, et al.
Endocrine, metabolic & immune disorders drug targets 2026; (26()):e18715303470784 doi:10.2174/0118715303470784260605093400.
PMID: 42333852 - 8
Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised? .
Sediva H, Dusatkova P, Kanderova V, et al.
Hormone research in paediatrics 2017; (88(2)):160-166 doi:10.1159/000456544.
PMID: 28253502 - 9
A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoimmunity.
Zhou Q, Chen D, Yu J, et al.
Molecular genetics & genomic medicine 2024; (12(2)):e2407 doi:10.1002/mgg3.2407.
PMID: 38404237 - 10
Endocrinopathies in children with inborn errors of immunity: a single-center experience.
Buyukyilmaz G, Toksoy Adiguzel K, Kocaay P, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2025; (38(7)):735-742 doi:10.1515/jpem-2024-0593.
PMID: 40270454 - 11
Reduction in mucosal phosphorylated STAT3 under therapy with JAK inhibitor in STAT3 gain of function mutation - a case study.
Oberli R, Mookhoek A, Denier D, et al.
Virchows Archiv : an international journal of pathology 2026; doi:10.1007/s00428-026-04409-1.
PMID: 41555056 - 12
Novel STAT-3 gain-of-function variant with hypogammaglobulinemia and recurrent infection phenotype.
Erdős M, Tsumura M, Kállai J, et al.
Clinical and experimental immunology 2021; (205(3)):354-362 doi:10.1111/cei.13625.
PMID: 34050927 - 13
Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patients.
Gothe F, Gehrig J, Rapp CK, et al.
Pediatric pulmonology 2021; (56(12)):3934-3941 doi:10.1002/ppul.25684.
PMID: 34549903
This page is for informational purposes only and does not constitute medical advice. It describes STAT3-GOF symptoms and disease course; follow your child's individualized fever plan and contact the treating team about concerning changes.